Fractional flow reserve of non-culprit vessel post-myocardial infarction: is it reliable?
Related Experiment Video
Updated: Mar 31, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Luís Leite1, Joana Moura Ferreira2, João Silva Marques3
1Departament of Cardiology, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, Coimbra, 3000-075, Portugal. luispcleite@gmail.com.
Insights
Fractional flow reserve (FFR) guided revascularization in non-culprit vessels after myocardial infarction requires caution. Early post-MI assessment may yield false negatives, impacting treatment decisions.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Physiology
Background:
- Multi-vessel coronary artery disease is common in myocardial infarction (MI) patients, influencing prognosis.
- Revascularization of non-culprit vessels is often guided by ischemia proven through non-invasive tests.
- Fractional flow reserve (FFR) is increasingly used in acute coronary syndrome (ACS) to assess lesion severity.
Observation:
- A case report details an FFR-guided strategy for non-culprit vessels three weeks post-ST-elevation myocardial infarction (STEMI).
- This strategy was followed by a transient, short-term sub-occlusion of the assessed non-culprit vessel.
Findings:
- The study highlights the uncertainty in coronary microcirculation recovery timing after MI, which can affect FFR accuracy.
- Potential for false-negative FFR results exists in the early post-MI period.
- Gaps in understanding the relationship between ischemia, plaque vulnerability, and FFR require further investigation.
Implications:
- FFR-guided revascularization decisions in the early post-MI phase warrant careful consideration.
- Clinical interpretation of FFR in the context of recent MI needs to account for potential microcirculatory dysfunction.
- Further research is needed to optimize the timing and application of FFR in managing multi-vessel disease post-MI.
Background:
Multi-vessel disease is frequent in patients presenting with myocardial infarction and have an important prognostic impact. The decision to proceed to revascularization in non-culprit vessels can be postponed until ischemia is proven in non-invasive stress tests. On the other hand, there is an increasing evidence to support the role of fractional flow reserve (FFR) in acute coronary syndrome setting.
Case Presentation:
We report a case in which a FFR-guided strategy for non-culprit vessels, 3 weeks after an ST-segment elevation myocardial infarction, was followed by a short-term sub-occlusion of the evaluated vessel.
Conclusion:
The timing of the coronary microcirculation recovery post-myocardial infarction, avoiding a possible false negative FFR, and the diagnostic gaps between ischemia and plaque vulnerability are under discussion. An FFR-guided strategy in this setting should be interpreted with caution.

